Research & Reviews : A Journal of Immunology

ISSN: 2277-6206

Editors Overview

rrjoi maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue

Development of immunotherapy treatments

Abstract Submission Deadline : November 30, 2024

Manuscript Submission Deadline : December 25, 2024

Special Issue Description

Immunotherapy is a cancer treatment method. It boosts the immune system and helps the body find and destroy cancer cells by using substances made by the body or in a laboratory. Immunotherapy can be used to treat a wide range of cancers. It can be used alone or with chemotherapy and/or other cancer treatments. Several recent developments have marked the advancement of tumor immunology and immunotherapy. There are several types of immunotherapies, and each helps the immune system differently. For example, the administration of interleukin-2 (IL-2) to cancer patients demonstrated that an immunological manipulation could mediate the regression of established growing cancers in humans.


Cancer Treatment, Immunotherapy, Immune system, Tumor immunology, Interleukin-2 (IL-2)

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals: